Upon clinicopathological correlation of PD-L1 expression to outcomes in patients with ALK-rearranged NSCLC, PD-L1 expression had no influence on disease-free survival among patients who underwent surgical resection. The gene discussed is ALK; the disease is non-small cell lung carcinoma.